ALNY · Alnylam Pharmaceuticals, Inc. · Investor Relations
$165.04
+8.39 (+5.36%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$22.11B
Shares
133.94M
Volume · Nov 13
3.59M
Avg daily vol (3M)
2.04M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-18 15:00 UTC | Jefferies Global Healthcare Conference | Conference |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-29 | Alnylam Pharmaceuticals Q3 2026 Earnings Conference Call | Earnings call |
| 2026-10-26 | RNAi Roundtable: HTT02 | Event |
| 2026-09-17 | Zilebesiran RNAi Roundtable | Event |
| 2026-09-17 | RNAi Roundtable: zilebesiran | Event |
| 2026-09-14 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-07-30 | Alnylam Pharmaceuticals Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-25 | RNAi Roundtable: ALN-6400, Targeting Plasminogen to Address Rare Bleeding Disorders | Event |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-13 | BofA Securities Healthcare Conference | Conference |
| 2026-04-30 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-12 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
| 2025-10-30 | Alnylam Pharmaceuticals 3Q 2025 Earnings Conference Call | Earnings call |
| 2025-07-31 | Alnylam Q2 2025 Conference Call | Earnings call |
Source: https://investors.alnylam.com/
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
589 filings
542 filers
Visit website
Investor relations